As metabolic medicine evolves, new diagnostics and monitoring tools are becoming essential to delivering better outcomes
The Metabolic Membership helps bridge that
The health shield bridging modern
protocols and outdated care
Our metabolic pathway is built around best-in-class clinical outcomes, and maintaining that standard requires consistency. Metabolic medicine is evolving faster than insurance coverage and clinical guidelines, with new evidence supporting advanced tests like AI powered risk stratification diagnostics , hormone tests, and indirect calorimetry.
The Metabolic Shield ensures
Clinically essential tests are never omitted
Care timelines remain uninterrupted
Advanced diagnostics used when indicated
Your 12-month roadmap stays fully intact
Decisions guided by medical need
Monitoring protects muscle and metabolism
Follow-up remains consistent throughout care
Coverage never limits clinical standards
In simpler words, The Metabolic Shield protects the parts of your care that evidence-based metabolic medicine increasingly depends on.
Eligibility criteria
The Metabolic Membership is a physician-prescribed clinical program available only to patients who meet defined medical criteria and are assessed as appropriate for enrollment.
1
Check eligibility
- Documented medical condition, confirmed by your treating physician
- Qualifying conditions: diabetes/prediabetes, metabolic syndrome, liver disorders, thyroid or other endocrine disorders, dyslipidemia/hypertension
- 18+ only
- Final call made in consultation based on physician judgment, history, and risk profile decide it
2
Meet the membership team
- Benefits and 12-month protocol explained
3
Enroll and activate
- Start using your membership perks
Where insurance variability affects a 12-month care plan
Where insurance variability affects a 12-month care plan
| Assessment | Insurance rejection probability | Typical insurance behaviour over time |
|---|---|---|
|
ECAL / metabolic testing
|
Very high
|
Often classified as non-essential or investigational across plans
|
|
Liver elastography
|
High
|
Approvals often depend on disease severity instead of preventive care
|
|
Hormonal / advanced Markers
|
High
|
Optimal hormone optimisation require continuous testing excluded from most plans
|
|
Follow-up cadence
|
High
|
Coverage supports episodic care, not structured longitudinal follow-up
|
|
BMD scan (including Dexa when required
|
High
|
Approved only under defined risk criteria
|
|
Dietitian consultation
|
Moderate-high
|
Discontinued without renewed justification
|
|
Retinal imaging
|
Moderate-high
|
Repeat imaging may be time-restricted
|
|
ECG / ABI / cardiac screening
|
Moderate
|
Advanced cardiac screening often inconsistently approved
|
|
Ultrasound abdomen
|
Moderate
|
Repeat approvals may require new symptoms or justification
|
|
Full metabolic panel
|
Low-moderate
|
Frequency and panel breadth may be restricted
|
|
Physician consultation
|
Low
|
Follow-up approvals may be capped annually or require re-authorization
|
Your care plan should not change because of administrative approvals. It should change only because your health requires it.